https://www.selleckchem.com/products/bay-985.html
Soluble suppression of tumorigenesis-2 (sST2) was reported to be associated with cognitive performance and risk of incident stroke. However, the impact of sST2 on cognitive function after ischemic stroke is unclear. We aimed to assess the association of sST2 and cognitive impairment at 3 months in acute ischemic stroke patients. Baseline plasma sST2 levels were measured in 619 ischemic stroke patients (mean age 60.0 ± 10.5 years) from 7 participating hospitals of the China Antihypertensive Trial in Acute Ischemic Stroke. Montreal Cognit
Beğen
Yorum Yap
Paylaş
